Literature DB >> 27122186

Rapid identification and antimicrobial susceptibility testing of positive blood cultures using MALDI-TOF MS and a modification of the standardised disc diffusion test: a pilot study.

C Fitzgerald1, P Stapleton1, E Phelan1, P Mulhare1, B Carey1, M Hickey1, B Lynch1, M Doyle1.   

Abstract

AIMS: In an era when clinical microbiology laboratories are under increasing financial pressure, there is a need for inexpensive, yet effective, rapid microbiology tests. The aim of this study was to evaluate a novel modification of standard methodology for the identification and antimicrobial susceptibility testing (AST) of pathogens in positive blood cultures, reducing the turnaround time of laboratory results by 24 h.
METHODS: 277 positive blood cultures had a Gram stain performed and were subcultured and incubated at 37°C in a CO2 atmosphere for 4-6 h. Identification of the visible growth was performed using matrix-assisted laser desorption time of flight mass spectrometry (MALDI-TOF MS). Taking a modified approach to the Clinical and Laboratory Standards Institute-standardised AST methodology, an inoculum density of 0.5 McFarland was prepared from the early growth for disc diffusion testing. The standard AST method was also performed on the 18-24 h culture.
RESULTS: 96% (n=73/76) of gram-negative organisms were correctly identified by MALDI-TOF MS. Comparative analysis of the rapid and standard AST results showed an overall interpretive category error rate of 7.7% (6.7% minor errors, 0.6% major errors and 0.4% very major errors). 100% of Staphylococcus aureus (n=41) and enterococcus isolates (n=9) were correctly identified after 4-6 h incubation. The overall AST categorical agreement was also 100% for these isolates.
CONCLUSIONS: An incubation of 4-6 h directly from positive blood cultures allowed for both a rapid species identification and an antimicrobial susceptibility result approximately 24 h earlier than is possible using standard methodology. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/

Entities:  

Keywords:  ANTIMICROBIAL RESISTANCE; BACTERAEMIA; BLOOD CULTURE; MICROBIOLOGY

Year:  2016        PMID: 27122186     DOI: 10.1136/jclinpath-2015-203436

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  3 in total

1.  How small modifications in laboratory workflow of blood cultures can have a significant impact on time to results.

Authors:  B Van den Poel; A Klak; S Desmet; J Verhaegen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2018-06-30       Impact factor: 3.267

2.  Performance and potential clinical impact of Alfred60AST (Alifax®) for direct antimicrobial susceptibility testing on positive blood culture bottles.

Authors:  Bea Van den Poel; Philippe Meersseman; Yves Debaveye; Adrian Klak; Jan Verhaegen; Stefanie Desmet
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2019-10-17       Impact factor: 3.267

3.  EUCAST rapid antimicrobial susceptibility testing (RAST) in blood cultures: validation in 55 European laboratories.

Authors:  Anna Åkerlund; Emma Jonasson; Erika Matuschek; Lena Serrander; Martin Sundqvist; Gunnar Kahlmeter
Journal:  J Antimicrob Chemother       Date:  2020-11-01       Impact factor: 5.790

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.